BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30984327)

  • 1. Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.
    Bawa MK; Mamman A; Olayinka A; Gidado S; Waziri NE; Balogun MS; Getso KI; Dalhat MM; Nsubuga P; Aliyu N; Bala H; Muhammad H; Haladu S; Shehu UL; Nguku PM
    Pan Afr Med J; 2019; 32(Suppl 1):6. PubMed ID: 30984327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
    Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
    East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil.
    Souza MA; Passos AM; Treitinger A; Spada C
    Rev Soc Bras Med Trop; 2010; 43(4):359-61. PubMed ID: 20802930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
    Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
    East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.
    Fowotade A; Okonko IO; Agbede OO; Suleiman ST
    Afr Health Sci; 2015 Mar; 15(1):1-9. PubMed ID: 25834524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
    Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria.
    Alao OO; Mamman A; Araoye MO; Joseph E
    Niger Postgrad Med J; 2009 Jun; 16(2):139-42. PubMed ID: 19606194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
    Das B; Kaur G; Basu S
    Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
    Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
    Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology Study of Cytomegalovirus and Rubella among Pregnant Women at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Yeshwondm M; Balkachew N; Delayehu B; Mekonen G
    Ethiop J Health Sci; 2016 Sep; 26(5):427-438. PubMed ID: 28446848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
    Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
    J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of cytomegalovirus among pregnant women attending Murtala Mohammed Specialist Hospital Kano, Nigeria.
    Hamid KM; Onoja AB; Tofa UA; Garba KN
    Afr Health Sci; 2014 Mar; 14(1):125-30. PubMed ID: 26060468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
    Weber B; Fall EM; Berger A; Doerr HW
    J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan.
    Hamdan HZ; Abdelbagi IE; Nasser NM; Adam I
    Virol J; 2011 May; 8():217. PubMed ID: 21569321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection in a cohort of pregnant women.
    El Sanousi SM; Osman ZA; Mohmed AB; Al Awfi MS
    Am J Infect Control; 2016 Apr; 44(4):e41-3. PubMed ID: 26810886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus Infection among Pregnant Women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions.
    Jin Q; Su J; Wu S
    J Microbiol Biotechnol; 2017 May; 27(5):1005-1009. PubMed ID: 28285497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is seroprevalence of anti-IGM CMV among blood donors relevant in India?
    Kumar H; Gupta PK; Kumar S; Sarkar RS
    Indian J Pathol Microbiol; 2008; 51(3):351-2. PubMed ID: 18723956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
    Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
    Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The seroprevalence of cytomegalovirus antibodies among prospective blood donors in Jos.
    Alao OO; Joseph DE; Mamman A; Banwat EB
    Niger J Med; 2008; 17(2):198-200. PubMed ID: 18686839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.